If you’ve received a diagnosis or a suspicious biopsy result for melanoma or another form of skin cancer, the Johns Hopkins Melanoma/Skin Cancer Program is here to help. Our program brings together industry-leading care and world-class research. Our multidisciplinary group of renowned experts works as a team to determine individualized treatment plans and find clinical trials that are most likely to benefit our patients.
Our Approach to Care
A Multidisciplinary Team Committed to Each Individual Patient
At the Johns Hopkins Melanoma/Skin Cancer Program, we practice multi-disciplinary care for every single patient. This means that the entire care team — dermatologists, surgeons, medical oncologists, radiation oncologists, radiologists and pathologists— works together closely to make an accurate diagnosis and develop an individualized treatment plan.
Team members meet together weekly to review your case: test results, treatment plans, progress, next steps. This team approach allows for all of those caring for you across disciplines to coordinate their expertise and offer the best care options for you moving forward. We believe that collaborative care will help you make the right informed decisions.
You can feel confident knowing that your care team is in sync.
Access to the Most Advanced Treatments, Techniques and Clinical Trials
As some of the country’s leading experts in the diagnosis and treatment of common as well as rare and often aggressive forms of skin cancer, we are eager to share that knowledge.
Our clinicians are renowned cancer researchers actively working to develop new and better ways to fight the disease. With insights into newly available and on-the-horizon treatments, our team can offer suggestions on the suitability of clinical trial opportunities that may hold promise for many patients.
Moving for Melanoma of Delaware closes its doors after 15 years of service and sponsorship
Sept. 27, 2022 | After 15 years of service to the mid-Atlantic melanoma patient community, and a decade-long research partnership with the Johns Hopkins Melanoma/Skin Cancer Program, Moving for Melanoma of Delaware is closing its doors in 2022. This non-profit organization was co-founded by its president Anna Marie Farro in 2007, after her personal experience as a patient with melanoma, to promote awareness, honor loved ones, and raise funds for melanoma research. With the motto “We give where we live”, Moving for Melanoma of Delaware held inspiring annual 5K walk/run events, raising funds to support patients and research in Delaware, Maryland, Pennsylvania and New Jersey. A total of over $350,000 was donated to the Hopkins Melanoma Program, fostering groundbreaking immunotherapy research that led to vast improvements in melanoma survival and benefited countless numbers of patients. We will be forever grateful for our long-standing research partnership and friendship.
Dr. Suzanne Topalian Honored with AAMC Award
Suzanne Topalian, M.D., was recently honored with the 2021 Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges (AAMC).
Patients at the Johns Hopkins Melanoma/Skin Cancer Program have access to revolutionary clinical trials, as our researchers are constantly exploring new therapy targets. Hopkins was a leader in pioneering investigations of immune-based therapies involving PD-1 and LAG-3, proteins whose pathway can be blocked to restore the body’s ability to detect and attack cancer. Our clinical research programs offer studies for patients with various stages of melanoma and other skin cancers, ranging from preventing disease recurrence in high-risk surgical patients to developing innovative therapies for patients with advanced metastatic disease.
Johns Hopkins Kimmel Cancer Center's Melanoma Tumor Board
Grateful patients, friends, and families often ask what they can do to further the fight against melanoma and help support medical research that will lead to saving more lives.
Patients, friends and families can help win the fight against melanoma by supporting medical research that can help conquer this disease. Continued financial support helps us maintain our tradition of excellence in patient care and speed the discovery of new cures for melanoma.
Support the Hopkins Melanoma Program Fund by contacting the Johns Hopkins Kimmel Cancer Center Development Office at 410-361-6391.